Literature DB >> 13050814

The diagnostic use of amobarbital sodium (amytal sodium) in brain disease.

E A WEINSTEIN, R L KAHN, L A SUGARMAN, L LINN.   

Abstract

Entities:  

Keywords:  BARBITURATES/therapeutic use; BRAIN/diseases; NARCOSYNTHESIS

Mesh：

Substances：

Year:  1953        PMID： 13050814     DOI： 10.1176/ajp.109.12.889

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Neurological changes with intracarotid amytal and megimide in man.

Authors:  R WERMAN; N CHRISTOFF; P J ANDERSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-11       Impact factor: 10.154

2.  The renaissance of neuropsychiatry.

Authors:  L LINN
Journal:  Psychiatr Q       Date:  1955-07

Review 3.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

4.  Effects of intravenous sodium amobarbital vs lidocaine on pain and sensory abnormalities in patients with spinal cord injury.

Authors:  Angela Mailis-Gagnon; Balaji Yegneswaran; Bob Bharatwal; Andrei V Krassioukov
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.